Novo Nordisk's recent SELECT trial found that its weight loss drug, Wegovy, reduced major cardiovascular events by 20%. This finding can potentially change insurers' views on covering obesity treatments. However, they await more detailed information from the trial data before potentially changing […]
BioMarin’s Voxzogo Sales Forecast Rises Despite Supply Constraints
Voxzogo's success is posing challenges for BioMarin. Here's what you need to know: BioMarin's drug, Voxzogo, is performing better than expected, resulting in a bottleneck in the product's fill-finish capacity. The product exceeded sales forecasts and became a significant growth […]
Potential and Challenges of Blockchain Technology in Healthcare
Blockchain, a distributed ledger technology known for supporting cryptocurrencies, has garnered interest in the healthcare sector due to its ability to securely and transparently share data. Its use in healthcare includes improving health information exchange, managing medical records, and tracking […]
U.S. Physicians Earn $350K Average; Study Reveals Impact on Overall System Costs
The average U.S. physician earns $350,000 annually, with top doctors making ten times that amount. A study using tax records from over 10 million physicians over 13 years revealed that doctors earn more than any other occupation, with those in the top 1 percent making an average of $4 million. While […]
Sarepta Therapeutics Begins Dosing Duchenne Patients with Newly Approved Gene Therapy
Sarepta Therapeutics has started dosing Duchenne muscular dystrophy patients with its recently approved gene therapy, Elevidys, and plans to serve more in the coming week and a half. The regulatory body has granted approval for the treatment of four- and 5-year-old Duchenne patients, costing $3.2 […]
Medicare Drug Price Negotiations Predicted to Yield $1.8 Billion Savings by 2026
A new report asserts that the Inflation Reduction Act will enforce a minimum discount that surpasses the 2020 rebates for only 4 out of 10 negotiated Medicare drugs by 2026. The four drugs, Enbrel, Imbruvica, Ibrance, and Xtandi, will be subject to minimum discounts of 60% and 25%, respectively. The […]
EQRx to be Acquired by Revolution Medicines
EQRx, a company with the intention of disrupting the pharma pricing system, has agreed to be taken over by Revolution Medicines. As a result, Revolution will receive an additional $1 billion in capital reserves, supporting the progression of its cancer therapies. EQRx will terminate its R&D […]
Improving Data Privacy with Machine Learning!
Researchers from the Pacific Northwest National Laboratory (PNNL) and the University of Texas at El Paso are collaborating on a project to improve the privacy and security of sensitive data. The project, led by PNNL Data Scientist Tony Chiang and Mathematical Sciences Professor Amy Wagler, uses […]
Infectious Disease Market Projected to Grow by 5.7% Led by Pfizer, Gilead Sciences, and GSK
According to a report by GlobalData, the infectious disease market is projected to grow actively from 2023 to 2029 and sales are predicted to reach $150 billion by 2029. It is expected that Pfizer, Gilead Sciences, and GlaxoSmithKline (GSK) will be the major players in the market. What You Need […]
Pfizer Shakes Up R&D Leadership Team
Pfizer has changed its research and development (R&D) leadership team. The most prominent move includes the appointment of Chris Boshoff, MD, PhD, as Chief Oncology Research and Development Officer and EVP. He will be responsible for the entire oncology pipeline, reporting to CEO Albert Bourla. […]
GSK Preps for Fall Launch of RSV Vaccine; CEO Expects Slower Initial Uptake
What You Need to Know: GSK has developed a vaccine against the respiratory syncytial virus (RSV) and is preparing to launch it in the United States in the fall. CEO Emma Walmsley does not anticipate as quick an uptake for the RSV vaccine as was seen with the company's successful shingles […]
Proposing a Revolution in American Healthcare: Universal Basic Health Coverage
MIT Professors Amy Finkelstein and Liran Einav have proposed a total overhaul of the U.S. health insurance system, advocating for universal basic health coverage, in their book "We’ve Got You Covered: Rebooting American Health Care". The authors argue that the current patchwork of health policies […]
Medlinker’s AI Doctors Almost Match Human Physicians in Groundbreaking Live Test
Medlinker, a Chinese digital healthcare company, hosted a live comparison of its AI doctors, MedGPT, and human doctors in Chengdu, with MedGPT scoring 7.2 out of 10, compared to an average of 7.5 for human doctors, based on an assessment by seven notable physicians. Furthermore, the recommendations […]
FTC Sues to Block IQVIA’s Acquisition of Propel Media
The Federal Trade Commission (FTC) is attempting to block IQVIA Holdings from acquiring Propel Media, Inc., arguing that it would create an unfair market advantage in healthcare product advertising. Holly Vedova, FTC Bureau of Competition Director, explained, “Protecting competition in the emerging […]
Medical Affairs Outsourcing Market Forecasted to Reach $3.28B by 2027
The global Medical Affairs Outsourcing Market is forecast to reach $3,287.12 million by 2027 from $1,415.00 million in 2019, growing at a CAGR of 11.2% from 2020 to 2027. Key players include PPD, Inc., ICON plc, and Accelerated Enrollment Solutions (AES), which have expanded services and made […]
Idorsia Sells Major Portion of Asia Pacific Operations for $465.8 Million
Swiss biopharma company Idorsia has sold a significant portion of its Asia Pacific operations, excluding China, to Sosei Heptares for $465.8 million. This includes their affiliates in Japan and South Korea and rights to several Idorsia drugs. In addition, the deal grants "...a license for the […]
Peterson Center on Healthcare Launches Institute to Evaluate Digital Health Technologies
The Peterson Center on Healthcare has launched the Peterson Health Technology Institute (PHTI). The PHTI is a nonprofit organization dedicated to evaluating and assessing innovative healthcare technologies. With a $50 million commitment from the Peterson Center, PHTI aims to analyze the clinical […]
Novo Nordisk Grapples with Supply Shortage Amid Surging Demand for Weight-Loss Drugs
Novo Nordisk is facing a supply shortage for its weight-loss drugs, Wegovy and Saxenda, due to surging demand… Here’s What You Need to Know: After initial Wegovy shortages, customers turned to Saxenda for a replacement, leading to its limited availability through the end of 2023 and possibly […]
ITIF Report: Global Drug Price Controls Restrict Pharmaceutical Research and Development
The Information Technology and Innovation Foundation (ITIF) study reports that drug price controls in non-US Organization for Economic Cooperation and Development (OECD) nations inhibit biopharmaceutical R&D by over $56 billion annually, foregoing the creation of around 25 new drugs yearly. If […]
BridgeBio’s Experimental Results Boosts Company Shares by 65%
BridgeBio Pharma Inc's experimental drug, acoramidis, for rare heart disease, has shown significant improvement in a late-stage study, boosting its market shares by 65%. Acoramidis functions to prevent heart failure by addressing anomalous protein deposits in the heart. It is expected to compete […]
J&J Subsidiary Sues Doctors Over Talc-Cancer Research
Johnson & Johnson's subsidiary LTL Management has filed lawsuits against four doctors who have published studies suggesting links between J&J's talc-based care products, including Baby Powder, and cancer. The company insists these studies are inaccurate and demands a retraction or […]
Sequoia Project and AHIMA Launch Health Data Usability Project
The Sequoia Project and the American Health Information Management Association (AHIMA) have partnered on the initiative "Data Usability Taking Root." They designed this project to enhance the quality and actionability of the health information that end users receive within their workflows. Eleven […]
BioGeneration Ventures Finalizes $167M Fund for Biotech Startups in Europe
What You Need To Know: Dutch venture capital firm BioGeneration Ventures (BGV) has secured €150 million ($167 million) for its fifth fund. The firm bases itself in Naarden, Netherlands, focusing on European drug developers. However, 78% of the new investors, forming most of the new investor […]
Insights into the Global Real World Evidence Solutions Market 2023-2030
10 Things You Need to Know: The projection shows the market size growing from $16.3 billion in 2023 to $36.24 billion in 2030, with a CAGR of 12.3%. IQVIA Inc., UnitedHealth Group, IBM, and Cognizant are currently the major players to pay attention to in the market. Advanced analytics […]
Unmasking Healthcare Costs: Beyond Transparency
What You Need to Know: Policymakers have shifted focus towards price transparency in healthcare to combat escalating costs; however, merely comprehending the cost increase will not tackle the entire issue. Healthcare providers and health plans must post their prices online under federal […]
Is AI the Future of Pharma?
Here's What People Are Saying... ChatGPT is revolutionizing the pharmaceutical industry. Artificial intelligence and machine learning are expediting medication development, tailoring drug distribution, and improving the process of drug commercialization. Big pharma companies like Pfizer, Merck […]
Price Break: Cigna Welcomes Trio of Discounted Biosimilars to Preferred Drug Roster
What You Need to Know: Cigna Group's unit, Express Scripts, is adding three biosimilar versions of AbbVie's arthritis treatment Humira to its preferred drugs list. Reuters explains that “The biosimilars include Hyrimoz and an unbranded version of Humira from Swiss drugmaker Novartis' […]
Thermo Fisher to Acquire Data Firm CorEvitas for $912.5M
What You Need to Know: For $912.5 million, Thermo Fisher Scientific is set to acquire CorEvitas, a real-world data intelligence company. CorEvitas has developed a platform that collects structured clinical patient data from over 400 sites and more than 100,000 patients. According to Fierce, […]
Accelerating the Rise of Value-Based Care
Enacting value-based care payment models has been a priority of payer and provider organizations in recent years, but the implementation has been uneven, with care centers serving underprivileged or vulnerable populations being left in the lurch. Helping close the gap is pivotal to reaching the US […]
Looking Back at the Orphan Drugs Act
In 1983, the US Congress passed the Orphan Drug Act (ODA) that offers financial incentives for developing drugs for rare diseases that have limited, if any, approved therapeutics. A new study published in the Orphanet Journal of Rare Diseases explores the impact that the ODA has had on the field of […]
